OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Dennis Selkoe

1 Projects | 1 Researchers | $307,782 Invested

2016

Brigham and Women's Hospital

Dennis Selkoe, MD

Neurally-derived exosomes for the diagnosis and staging of sporadic Alzheimer's disease

  • Funding Amount: $307,782
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: zzAbeta
  • Status: Closed